vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (IBCP) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($58.9M vs $44.6M, roughly 1.3× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). INDEPENDENT BANK CORP runs the higher net margin — 28.6% vs -90.4%, a 119.1% gap on every dollar of revenue. Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 2.1%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

IBCP vs PACB — Head-to-Head

Bigger by revenue
IBCP
IBCP
1.3× larger
IBCP
$58.9M
$44.6M
PACB
Higher net margin
IBCP
IBCP
119.1% more per $
IBCP
28.6%
-90.4%
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
2.1%
IBCP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IBCP
IBCP
PACB
PACB
Revenue
$58.9M
$44.6M
Net Profit
$16.9M
$-40.4M
Gross Margin
37.1%
Operating Margin
-92.3%
Net Margin
28.6%
-90.4%
Revenue YoY
13.8%
Net Profit YoY
8.2%
-1802.7%
EPS (diluted)
$0.81
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBCP
IBCP
PACB
PACB
Q1 26
$58.9M
Q4 25
$58.3M
$44.6M
Q3 25
$57.3M
$38.4M
Q2 25
$55.9M
$39.8M
Q1 25
$54.1M
$37.2M
Q4 24
$62.0M
$39.2M
Q3 24
$51.4M
$40.0M
Q2 24
$56.5M
$36.0M
Net Profit
IBCP
IBCP
PACB
PACB
Q1 26
$16.9M
Q4 25
$18.6M
$-40.4M
Q3 25
$17.5M
$-38.0M
Q2 25
$16.9M
$-41.9M
Q1 25
$15.6M
$-426.1M
Q4 24
$18.5M
$2.4M
Q3 24
$13.8M
$-60.7M
Q2 24
$18.5M
$-173.3M
Gross Margin
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Operating Margin
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
34.8%
-92.3%
Q3 25
37.0%
-101.1%
Q2 25
37.0%
-112.8%
Q1 25
35.3%
-1154.5%
Q4 24
36.7%
-390.1%
Q3 24
33.7%
-160.3%
Q2 24
41.0%
-488.3%
Net Margin
IBCP
IBCP
PACB
PACB
Q1 26
28.6%
Q4 25
31.8%
-90.4%
Q3 25
30.5%
-98.9%
Q2 25
30.2%
-105.4%
Q1 25
28.8%
-1146.8%
Q4 24
29.8%
6.0%
Q3 24
26.9%
-151.9%
Q2 24
32.8%
-481.3%
EPS (diluted)
IBCP
IBCP
PACB
PACB
Q1 26
$0.81
Q4 25
$0.88
$-0.11
Q3 25
$0.84
$-0.13
Q2 25
$0.81
$-0.14
Q1 25
$0.74
$-1.44
Q4 24
$0.87
$-0.44
Q3 24
$0.65
$-0.22
Q2 24
$0.88
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBCP
IBCP
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$174.9M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$510.6M
$5.3M
Total Assets
$5.6B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBCP
IBCP
PACB
PACB
Q1 26
$174.9M
Q4 25
$138.4M
$279.5M
Q3 25
$208.7M
$298.7M
Q2 25
$146.2M
$314.7M
Q1 25
$128.1M
$343.1M
Q4 24
$119.9M
$389.9M
Q3 24
$121.6M
$471.1M
Q2 24
$214.3M
$509.8M
Stockholders' Equity
IBCP
IBCP
PACB
PACB
Q1 26
$510.6M
Q4 25
$503.0M
$5.3M
Q3 25
$490.7M
$36.1M
Q2 25
$469.3M
$61.5M
Q1 25
$467.3M
$91.6M
Q4 24
$454.7M
$506.6M
Q3 24
$452.4M
$453.1M
Q2 24
$430.5M
$492.7M
Total Assets
IBCP
IBCP
PACB
PACB
Q1 26
$5.6B
Q4 25
$5.5B
$784.1M
Q3 25
$5.5B
$803.2M
Q2 25
$5.4B
$825.5M
Q1 25
$5.3B
$860.8M
Q4 24
$5.3B
$1.3B
Q3 24
$5.3B
$1.5B
Q2 24
$5.3B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBCP
IBCP
PACB
PACB
Operating Cash FlowLast quarter
$-19.1M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
$76.7M
$-19.1M
Q3 25
$18.2M
$-18.7M
Q2 25
$19.0M
$-29.4M
Q1 25
$31.7M
$-44.1M
Q4 24
$63.2M
$-30.6M
Q3 24
$17.2M
$-45.5M
Q2 24
$8.7M
$-54.3M
Free Cash Flow
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
$70.2M
$-19.9M
Q3 25
$16.5M
$-18.8M
Q2 25
$16.7M
$-29.9M
Q1 25
$30.6M
$-45.4M
Q4 24
$55.2M
$-32.3M
Q3 24
$15.7M
$-46.3M
Q2 24
$7.0M
$-55.7M
FCF Margin
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
120.3%
-44.6%
Q3 25
28.9%
-48.9%
Q2 25
29.8%
-75.3%
Q1 25
56.5%
-122.3%
Q4 24
89.1%
-82.3%
Q3 24
30.6%
-115.7%
Q2 24
12.3%
-154.8%
Capex Intensity
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
11.1%
1.9%
Q3 25
2.9%
0.2%
Q2 25
4.1%
1.4%
Q1 25
2.1%
3.7%
Q4 24
12.8%
4.1%
Q3 24
2.9%
2.0%
Q2 24
3.1%
4.1%
Cash Conversion
IBCP
IBCP
PACB
PACB
Q1 26
Q4 25
4.13×
Q3 25
1.04×
Q2 25
1.12×
Q1 25
2.03×
Q4 24
3.42×
-12.93×
Q3 24
1.25×
Q2 24
0.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBCP
IBCP

Net Interest Income$46.9M80%
Noninterest Income$12.0M20%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons